Emtricitabine with tenofovir alafenamide fumarate in HIV infection: additional benefits not covered

15 August 2016 - Deviation from the appropriate comparator therapy/higher loss for certain patients. ...

Read more →

HIV-positive children and adolescents: additional benefit of rilpivirine not proven

1 April 2016 - Under the trade name Edurant, rilpivirine hydrochloride as single agent has been approved already since 2011 for ...

Read more →